Controlled Substances News & Updates
2023
Past Articles
- 2022
-
2022 April- DEA Requiring Online Submission Applications and Renewals
2022 April- Placement of Five Synthetic Cannabinoids in Schedule I
2022 July 27th- Withdrawal of proposed rule for placement as Schedule I the following: Placement of 4-hydroxy-N,N-diisopropyltryptamine (4-OH-DiPT), 5-methoxy-alpha-methyltryptamine (5-MeO-AMT), 5-methoxy-N-methyl-N-isopropyltryptamine (5-MeO-MiPT), 5-methoxy-N,N-diethyltryptamine (5-MeO-DET), and N,N-diisopropyltryptamine (DiPT)
2022 July 19th-Federal Registry Notice- Schedules of Controlled Substances: Removal of Fenfluramine From Control - 2021
2021 01-12 Controlled Substances News - January 2021
2021 01-06 Controlled Substances Training Now Available
2021 10-05 DEA is Implementing Mandatory Use of Single Sheet DEA 222 Order Form- 2020
- 2020 12-14 2021 Inspections
2020 11-19 Holiday Closure and Ordering
2020 11-10 Controlled Substance Hours of Operation Update
2020 08-17 Controlled Substance Hours of Operation Update
2020 07-29 DEA - Federal Registration Notice
2020 07-28 DEA - Extortion Scam Targeting DEA Registrants
2020 04-30 Controlled Substance Hours of Operation Update
2020 04-15 DEA COVID-19 Information
2020 01-14 Buprenorphine Extended Release - 2019
- 2019 12-11 Winter Closure and Ordering
2019 11-5 DEA - CSP News & Updates- Heparin Shortage
2019 10-23 DEA - New Online System Suspicious Orders Report System (SORS)